who is not a good candidate for semaglutide (and is Not) GLP-1 Weight Loss? Semaglutide or Tirzepatide for Weight

This review examines the biological mechanisms underlying GLP-1 RA therapy in MASLD/MASH, analyzes the mechanistic distinctions between mono-, dual-, and triple agonists, and synthesizes current clinical evidence supporting their utilization in individuals with this condition

GLP-1s (short for glucagon-like peptide-1 receptor agonists) are medications that mimic a hormone your body already produces in the gut

Repeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of rats

and Kentucky

Patients should inform their surgeon and anesthesiologist about semaglutide use well in advance of any planned surgery to allow for individualized planning

How the NEX Platform Solves These Challenges Pharma companies shouldnt have to build custom digital platforms for every new therapy they create